VRTX Working Capital Ratio

Vertex Pharmaceuticals · Working Capital Ratio

VRTX logo

VRTX Working Capital Ratio

Latest reported28.08%
VRTX FY Working Capital Ratio (32.61% → 28.08%)
High-resolution chart · PNG

VRTX working capital ratio history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Working Capital Ratio — Annual fiscal periods
Period endingWorking Capital Ratio
28.0758%
26.7685%
46.6199%
57.8082%
55.2287%
53.2335%
41.9308%
43.5937%
51.9373%
35.9046%
36.0821%
50.4324%
51.3465%
41.9297%
42.5947%
33.7452%
52.2703%
66.3979%
49.4735%
56.4674%
51.8785%
45.2638%
62.7736%
72.5709%
73.9937%
56.0804%
76.0237%
88.4716%
90.6292%
87.1777%
79.899%
86.833%
75.082%
78.6275%
85.8144%
32.6087%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.